Table 2

Improvement in vision for all the patients in the trial

Improvement in logMAR visionCIsp Value
Baseline and week 3−0.04−0.63 to −0.20<0.001
Baseline and week 6−0.07−0.11 to −0.047<0.0001
Baseline and week 10−0.067−0.097 to 0.038<0.0001
  • Significance testing was performed using a paired t test and probability values calculated on the basis of two-tailed.